In Vivo Studies of the Foreign Body Reaction to Biomedical

Total Page:16

File Type:pdf, Size:1020Kb

In Vivo Studies of the Foreign Body Reaction to Biomedical IN VIVO STUDIES OF THE FOREIGN BODY REACTION TO BIOMEDICAL POLYMERS by Junghoon Yang Submitted in partial fulfillment of the requirements For the degree of Master of Science Thesis Adviser: Dr. James M. Anderson Department of Biomedical Engineering CASE WESTERN RESERVE UNIVERSITY May, 2013 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of Junghoon Yang candidate for the Master of Science in Biomedical Engineering. Chair of the Committee Dr. James M. Anderson Members of the Committee Dr. Horst von Recum Dr. Roger Marchant Date of Defense: March 7th, 2013 Table of Contents List of Tables………………………………………………………………………..ii List of Figures……………………………………………………………………….iv Abstract……………………………………………………………………………..vii Chapter I: Introduction………………………………………………………………1 Chapter II: Quantitative Versus Qualitative Assessment of the Extent of Foreign Body Reaction (Percent Fusion, Cell Density, and Nuclei Density)……...7 Materials and Methods……………………………………………………….11 Results………………………………………………………………………...31 Discussion……………………………………………………………………..65 References…………………………………………………………………….70 Chapter III: Controlling Fibrous Capsule Formation through Long-Term Down-Regulation of Collagen Type 1 (COL1A1) Expression by Nanofiber- Mediated siRNA Gene Silencing……………………………………………………….73 Materials and Methods…………………………………………………………75 Results…………………………………………………………………………..79 Discussion……………………………………………………………………….84 i List of Tables Chapter II Table 1. Animal Phenotype Table Indicating Strain, General Information, Specific Traits, and References………………………………………………………….9 Table 2. Quantitative Percent Fusion for PEU with Timepoints 14, 21, and 28 Days…..37 Table 3. Average Cell Density for PEU with Timepoints 14, 21, and 28 Days…………39 Table 4. Average Nuclei Density for PEU with Timepoints 14, 21, and 28 Days………41 Table 5. Qualitative Normalized Average Grading for PEU with Timepoints 14, 21, and 28 Days…………………………………………………………43 Table 6. Quantitative Percent Fusion for PET with Timepoints 14, 21, 28 Days ………45 Table 7. Average Cell Density for PET with Timepoints 14, 21, and 28 Days………….47 Table 8. Average Nuclei Density for PET with Timepoints 14, 21, and 28 Days……….49 Table 9. Qualitative Normalized Average Grading for PET with Timepoints 14, 21, and 28 Days…………………………………………………………51 Table 10. One-way ANOVA Testing for Percent Fusion P Values between Two Different Strains for Material PEU…………………………………………………53 Table 11. One-way ANOVA Testing for Percent Fusion P Values between Two Different Strains for Material PET…………………………………………………54 Table 12. One-way ANOVA Testing P Values between the Percent Fusion for the Two Materials, PEU and PET, for Experimental Strain Groups with BALB/cJ Control…………………………………………………………………...55 Table 13. One-way ANOVA Testing P Values between the Percent Fusion for the Two Materials, PEU and PET, for Experimental Strain Groups with c57 Control…………………………………………………………………………55 Table 14. One-way ANOVA Testing P Values between the Cell Density for the Two Materials, PEU and PET, for Experimental Strain Groups with BALB/cJ Control…………………………………………………………………...55 Table 15. One-way ANOVA Testing P Values between the Cell Density for the Two Materials, PEU and PET, for Experimental Strain Groups with c57 Control…………………………………………………………………………55 Table 16. One-way ANOVA Testing P Values between the Nuclei Density for the Two Materials, PEU and PET, for Experimental Strain Groups with BALB/cJ Control…………………………………………………………………...56 ii Table 17. One-way ANOVA Testing P Values between the Nuclei Density for the Two Materials, PEU and PET, for Experimental Strain Groups with c57 Control…………………………………………………………………………56 Table 18. One-way ANOVA Testing P Values between the Normalized Grading for the Two Materials, PEU and PET, for Experimental Strain Groups with BALB Control………………………………………………………56 Table 19. One-way ANOVA Testing P Values between the Normalized Grading for the Two Materials, PEU and PET, for Experimental Strain Groups with c57 Control………………………………………………………….56 Table 20. One-way ANOVA Testing P Values between the Percent Fusion for the Two Time Points with Material PEU…………………………………………….57 Table 21. One-way ANOVA Testing P Values between the Percent Fusion for the Two Time Points with Material PET…………………………………………….58 Table 22. One-way ANOVA Testing P Values between the Cell Density for the Two Time Points with Material PEU……………………………………………59 Table 23. One-way ANOVA Testing P Values between the Cell Density for the Two Time Points with Material PET…………………………………………….60 Table 24. One-way ANOVA Testing P Values between the Nuclei Density for the Two Time Points with Material PEU……………………………………………61 Table 25. One-way ANOVA Testing P Values between the Nuclei Density for the Two Time Points with Material PET…………………………………………….62 Table 26. One-way ANOVA Testing P Values between the Normalized Grading for the Two Time Points with Material PEU…………………………………..63 Table 27. One-way ANOVA Testing P Values between the Normalized Grading for the Two Time Points with Material PET…………………………………...64 iii List of Figures Chapter I Figure 1. Macrophage adherent cell density at Days 7 (A), 14 (B), and 21 (C) postimplantation in BALB/c and nude BALB/c mice……………………….2 Figure 2. Percent fusion at Days 14 (A) and 21 (B) post-implantation in BALB/c and nude BALB/c mice……………………………………………………...4 Chapter II Figure 1. Foreign body giant cell formation for BALB/c control on PEU surfaces at (A) 14 days, (B) 21 days, and (C) 28 Days…………………………17 Figure 2. Foreign body giant cell formation for NKT deficient mice on PEU surfaces at (A) 14 days, (B) 21 days, and (C) 28 Days…………………………18 Figure 3. Foreign body giant cell formation for IL-4 receptor alpha deficient mice on PEU surfaces at (A) 14 days, (B) 21 days, and (C) 28 Days…………19 Figure 4. Foreign body giant cell formation for c57 control on PEU surfaces at (A) 14 days, (B) 21 days, and (C) 28 Days…………………………20 Figure 5. Foreign body giant cell formation for NK deficient mice on PEU surfaces at (A) 14 days, (B) 21 days, and (C) 28 Days…………………………21 Figure 6. Foreign body giant cell formation for mast cell deficient mice on PEU surfaces at (A) 14 days, (B) 21 days, and (C) 28 Days…………………………22 Figure 7. Foreign body giant cell formation for SCID mice on PEU surfaces at (A) 14 days, (B) 21 days, and (C) 28 Days…………………………23 Figure 8. Foreign body giant cell formation for BALB/c control on PET surfaces at (A) 14 days, (B) 21 days, and (C) 28 Days………………………….24 Figure 9. Foreign body giant cell formation for NKT deficient mice on PET surfaces at (A) 14 days, (B) 21 days, and (C) 28 Days………………………….25 Figure 10. Foreign body giant cell formation for IL-4 receptor alpha deficient mice on PET surfaces at (A) 14 days, (B) 21 days, and (C) 28 Days………….26 Figure 11. Foreign body giant cell formation for c57 control on PET surfaces at (A) 14 days, (B) 21 days, and (C) 28 Days………………………….27 Figure 12. Foreign body giant cell formation for NK deficient mice on PET surfaces at (A) 14 days, (B) 21 days, and (C) 28 Days………………………….28 iv Figure 13. Foreign body giant cell formation for mast cell deficient mice on PET surfaces at (A) 14 days, (B) 21 days, and (C) 28 Days……………………29 Figure 14. Foreign body giant cell formation for SCID mice on PET surfaces at (A) 14 days, (B) 21 days, and (C) 28 Days………………………….30 Figure 15: Average Quantitative Percent Fusion for PEU with Control and Experimental Groups. Balb/cJ control for NKT Deficient and IL4-ra Deficient. c57 control for NK Deficient, SCID, and Mast Cell Deficient…..38 Figure 16: Average Cell Density for PEU with Control and Experimental Groups. Balb/cJ control for NKT Deficient and IL4-ra Deficient. c57 control for NK Deficient, SCID, and Mast Cell Deficient………………40 Figure 17: Average Nuclei Density for PEU with Control and Experimental Groups. Balb/cJ control for NKT Deficient and IL4-ra Deficient. c57 control for NK Deficient, SCID, and Mast Cell Deficient………………42 Figure 18: Average Normalized Qualitative Grading for PEU with Experimental and Control Groups. Balb/cJ control for NKT Deficient and IL4-ra Deficient. c57 control for NK Deficient, SCID, and Mast Cell Deficient………………………………………………………………………44 Figure 19: Average Quantitative Percent Fusion for PET with Control and Experimental Groups. Balb/cJ control for NKT Deficient and IL4-ra Deficient. c57 control for NK Deficient, SCID, and Mast Cell Deficient. ……………………………………………………………………..46 Figure 20: Average Cell Density for PET with Control and Experimental Groups. Balb/cJ control for NKT Deficient and IL4-ra Deficient. c57 control for NK Deficient, SCID, and Mast Cell Deficient………………48 Figure 21: Average Nuclei Density for PET with Controls and Experimental Groups. Balb/cJ control for NKT Deficient and IL4-ra Deficient. c57 control for NK Deficient, SCID, and Mast Cell Deficient………………50 Figure 22: Average Normalized Qualitative Grading for PET with Experimental and Control Groups. Balb/cJ control for NKT Deficient and IL4-ra Deficient. c57 control for NK Deficient, SCID, and Mast Cell Deficient………………………………………………………………….52 v Chapter III Figure 1. Histological images showing fibrous capsule formation and cell infiltration on aligned nanofibers supported on film at (a–h) week 2 and (i–p) week 4 with hematoxylin & eosin staining (left) and Masson’s Trichrome staining (right)………………………………………………………………..84 Figure 2 Histological images showing the fibrous capsule formation and cell infiltration on aligned nanofibers scaffolds that were supported on films at week 4 with hematoxylin & eosin staining (left) and Masson’s Trichrome staining (right). (a and b) siCOL1A1/CADY and (c and d) PCLEEP samples………………………………………………………….86 Figure 3 Quantitative analysis of (a) fibrous capsule thickness and (b) cell infiltration...87 vi IN VIVO STUDIES OF THE FOREIGN BODY REACTION TO BIOMEDICAL POLYMERS ABSTRACT by JUNGHOON YANG ABSTRACT The in vivo foreign body reaction on biomaterials regarding development of foreign body giant cells and formation of fibrous capsules was studied. The first study (chapter II) discusses the development of foreign body reaction with specific lymphocytic immunodeficient mice mainly targeting IL-4 (interleukin-4) cytokine.
Recommended publications
  • Thrombokinetics in Giant Cell Arteritis, with Special Reference to Corticosteroid Therapy
    Ann Rheum Dis: first published as 10.1136/ard.38.3.244 on 1 June 1979. Downloaded from Annals of the Rheumatic Diseases, 38, 1979, 244-247 Thrombokinetics in giant cell arteritis, with special reference to corticosteroid therapy ANNA-LISA BERGSTROM, BENGT-AKE BENGTSSON, LARS-BERTIL OLSSON, BO-ERIC MALMVALL, AND JACK KUTTI From the Departments of Internal Medicine and Infectious Diseases, Eastern Hospital, University of Gothenburg, S-416 85 Gothenburg, Sweden SUMMARY Duplicate platelet survival studies were carried out on 8 patients with giant cell arteritis (GCA), once before the institution of any therapy, and the second time when they were in a com- pletely asymptomatic phase after having received corticosteroid treatment. The time interval be- tween the studies ranged between 5 and 14 months. In the first study the mean peripheral platelet count was 486 ±25 x 109/1 and in the second 326 ±25 x 109/1. The difference between the means was highly significant (P<0 001). The mean life-span of the platelets was normal in the duplicate experiments (6 * 7 ±0 * 3 and 7 *3 ±0 *4 days, respectively). Platelet production rate was significantly (P<0 001) raised in the first experiment but became normal in response to corticosteroid therapy. It is concluded that the thrombocytosis seen in GCA is reactive to the inflammation present in this disease, and it seems reasonable to assume that the reduction in the peripheral platelet count which occurs in response to corticosteroid therapy accurately reflects the clinical improvement of the patient. Thrombocytosis is frequently present in patients Table 1 Eight patients with GCA in whom duplicate platelet sutrvival studies were carried out with untreated giant cell arteritis (GCA) (Olhagen, http://ard.bmj.com/ 1963; Hamrin, 1972; Malmvall and Bengtsson, Patients Age Sex Time interval Maintenance.
    [Show full text]
  • A Case of Discoid Lupus Erythematosus Masquerading As Acne
    Letters to the Editor 175 A Case of Discoid Lupus Erythematosus Masquerading as Acne Anastasios Stavrakoglou, Jenny Hughes and Ian Coutts Department of Dermatology, Hillingdon Hospital, Pield Heath Road, Uxbridge UB8 3NN, UK. E-mail: [email protected] Accepted July 4, 2007. Sir, On examination he had a widespread acneiform eruption, We describe here a case of discoid lupus erythemato- which was distributed on his face, pre-sternal area and back, particularly down the length of his spine. He had multiple sus (DLE) masquerading as acne vulgaris. Cutaneous brown-red follicular papules and open comedones, especially manifestations of lupus erythematosus (LE) are usually on his back, and hypopigmented atrophic scars. There were no characteristic enough to permit straightforward diagnosis. pustules or nodulocystic lesions (Fig. 1). However, occasionally they may be variable and mimic Treatment was started with erythromycin 500 mg bid and other dermatological conditions. adapalene cream once daily to treat a presumed diagnosis of acne vulgaris. He was seen 3 months later with a deterioration Acneiform presentation is one of the most rarely re- of his clinical appearance and increased pruritus. This was ported and one of the most confusing, as it resembles a attributed by the patient to increased sun exposure. The photo- very common inflammatory skin disease and therefore aggravation, the intense pruritus and the absence of pustules can be easily missed clinically. Only 5 cases have been and nodulocystic lesions broadened our differential diagnosis reported in the literature (1–4). The patient described and therefore diagnostic biopsies were obtained. A biopsy from the back where the rash was most suggestive clinically here presented with a widespread pruritic acneiform of acne vulgaris, showed hyperkeratosis with orthokeratosis, rash, which was initially diagnosed and treated as epidermal atrophy and extensive vacuolar degeneration of the acne vulgaris with no response.
    [Show full text]
  • Review Article
    J Clin Pathol: first published as 10.1136/jcp.36.7.723 on 1 July 1983. Downloaded from J Clin Pathol 1983;36:723-733 Review article Granulomatous inflammation- a review GERAINT T WILLIAMS, W JONES WILLIAMS From the Department ofPathology, Welsh National School ofMedicine, Cardiff SUMMARY The granulomatous inflammatory response is a special type of chronic inflammation characterised by often focal collections of macrophages, epithelioid cells and multinucleated giant cells. In this review the characteristics of these cells of the mononuclear phagocyte series are considered, with particular reference to the properties of epithelioid cells and the formation of multinucleated giant cells. The initiation and development of granulomatous inflammation is discussed, stressing the importance of persistence of the inciting agent and the complex role of the immune system, not only in the perpetuation of the granulomatous response but also in the development of necrosis and fibrosis. The granulomatous inflammatory response is Macrophages and the mononuclear phagocyte ubiquitous in pathology, being a manifestation of system many infective, toxic, allergic, autoimmune and neoplastic diseases and also conditions of unknown The name "mononuclear phagocyte system" was aetiology. Schistosomiasis, tuberculosis and leprosy, proposed in 1969 to describe the group of highly all infective granulomatous diseases, together affect phagocytic mononuclear cells and their precursors more than 200 million people worldwide, and which are widely distributed in the body, related by http://jcp.bmj.com/ granulomatous reactions to other irritants are a morphology and function, and which originate from regular occurrence in everyday clinical the bone marrow.' Macrophages, monocytes, pro- histopathology. A knowledge of the basic monocytes and their precursor monoblasts are pathophysiology of this distinctive tissue reaction is included, as are Kupffer cells and microglia.
    [Show full text]
  • Biomaterials and the Foreign Body Reaction: Surface Chemistry Dependent Macrophage Adhesion, Fusion, Apoptosis, and Cytokine Production
    BIOMATERIALS AND THE FOREIGN BODY REACTION: SURFACE CHEMISTRY DEPENDENT MACROPHAGE ADHESION, FUSION, APOPTOSIS, AND CYTOKINE PRODUCTION by JACQUELINE ANN JONES Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Dissertation Advisor: James Morley Anderson, M.D., Ph.D. Department of Biomedical Engineering CASE WESTERN RESERVE UNIVERSITY May, 2007 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of ______________________________________________________ candidate for the Ph.D. degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. Copyright © 2007 by Jacqueline Ann Jones All rights reserved iii Dedication This work is dedicated to… My ever loving and ever supportive parents: My mother, Iris Quiñones Jones, who gave me the freedom to be and to dream, inspires me with her passion and courage, and taught me the true meaning of friendship. My father, Glen Michael Jones, a natural-born teacher who taught me to be an inquisitive student of life, inspires me with his strength and perseverance, and gave me his kind, earnest heart that loves deeply and always
    [Show full text]
  • 2016 Essentials of Dermatopathology Slide Library Handout Book
    2016 Essentials of Dermatopathology Slide Library Handout Book April 8-10, 2016 JW Marriott Houston Downtown Houston, TX USA CASE #01 -- SLIDE #01 Diagnosis: Nodular fasciitis Case Summary: 12 year old male with a rapidly growing temple mass. Present for 4 weeks. Nodular fasciitis is a self-limited pseudosarcomatous proliferation that may cause clinical alarm due to its rapid growth. It is most common in young adults but occurs across a wide age range. This lesion is typically 3-5 cm and composed of bland fibroblasts and myofibroblasts without significant cytologic atypia arranged in a loose storiform pattern with areas of extravasated red blood cells. Mitoses may be numerous, but atypical mitotic figures are absent. Nodular fasciitis is a benign process, and recurrence is very rare (1%). Recent work has shown that the MYH9-USP6 gene fusion is present in approximately 90% of cases, and molecular techniques to show USP6 gene rearrangement may be a helpful ancillary tool in difficult cases or on small biopsy samples. Weiss SW, Goldblum JR. Enzinger and Weiss’s Soft Tissue Tumors, 5th edition. Mosby Elsevier. 2008. Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, Ye Y, Lau AW, Wang X, Oliveira AM. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest. 2011 Oct;91(10):1427-33. Amary MF, Ye H, Berisha F, Tirabosco R, Presneau N, Flanagan AM. Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool. Virchows Arch. 2013 Jul;463(1):97-8. CONTRIBUTED BY KAREN FRITCHIE, MD 1 CASE #02 -- SLIDE #02 Diagnosis: Cellular fibrous histiocytoma Case Summary: 12 year old female with wrist mass.
    [Show full text]
  • Dermatose Degenerativa Induzida Por D-Penicilamina Em Paciente Com Doença De Wilson
    Revista SPDV 76(2) 2018; D-Penicillamine induced degenerative dermopathy; Rui Pedro Santos, Joana Gomes, Celeste Brito. Caso Clínico Dermatose Degenerativa Induzida por D-penicilamina em Paciente com Doença de Wilson Rui Pedro Santos1, Joana Gomes2, Celeste Brito2 1Interno de Dermatovenereologia/Resident, Dermatovenereology, Hospital de Braga, Braga, Portugal 2Especialista de Dermatovenereologia/Specialist of Dermatovenereology, Hospital de Braga, Braga, Portugal RESUMO – As dermatoses degenerativas induzidas por D-penicilamina incluem, entre outras, a elastose perfurante serpiginosa e o pseudo-pseudoxantoma elástico. A elastose perfurante serpiginosa é uma doença perfurante rara caracterizada pela elimi- nação transepidérmica de fibras elásticas anormais. Esta condição pode ser idiopática, reativa ou induzida por D-penicilamina, habitualmente utilizada para o tratamento da doença de Wilson, cistinúria, artrite reumatóide ou esclerose sistémica. Manifesta- ções cutâneas semelhantes a pseudoxantoma elástico mas sem história familiar e mutações do gene ABCC6 foram identificadas como sendo uma dermatose induzida por D-penicilamina e designada de pseudo-pseudoxantoma elástico. Descreve-se o caso de uma mulher de 17 anos tratada por vários anos com D-penicilamina para doença de Wilson, com pápulas assintomáticas, algumas cor de pele e hiperqueratósicas e outras macias e amareladas, na região cervical e face. A histopatolo- gia mostrou a eliminação transepidérmica de fibras elásticas espessadas, em forma de dentes de serra. Estes achados sugeriram uma dermopatia induzida por D-penicilamina e os autores consideraram o diagnóstico de elastose perfurante serpiginosa e pseudo-pseudoxantoma elástico no mesmo paciente. O fármaco foi alterado para acetato de zinco sem lesões novas, mas com manutenção das lesões existentes no seguimento a 1 ano.
    [Show full text]
  • Analysis of Nine Cases of Oral Foreign Body Granuloma Related to Biomaterials
    J Biosci (2019) 44:78 Ó Indian Academy of Sciences DOI: 10.1007/s12038-019-9898-y (0123456789().,-volV)(0123456789().,-volV) Analysis of nine cases of oral foreign body granuloma related to biomaterials 1 1 1 LARISSA SANTOS AMARAL ROLIM ,CAIO CE´ SAR DA SILVA BARROS ,JULIANA CAMPOS PINHEIRO , 2 2 PATRI´CIA TEIXEIRA DE OLIVEIRA ,LE´ LIA BATISTA DE SOUZA and 3 PEDRO PAULO DE ANDRADE SANTOS * 1Oral Pathology Post-Graduation Program Student, Federal University of Rio Grande do Norte, Natal, RN, Brazil 2Oral Pathology Post-Graduation Program, Dentistry Department, Federal University of Rio Grande do Norte, Natal, RN, Brazil 3Oral Pathology Post-Graduation Program, Morphology Department, Federal University of Rio Grande do Norte, Natal, RN, Brazil *Corresponding author (Email, [email protected]) MS received 16 September 2018; accepted 10 April 2019; published online 2 August 2019 Foreign bodies can penetrate the interior of soft and, sometimes, hard, tissues in various ways, including through open wounds, lacerations and traumatic accidents. However over the years, evidence of links between the use of dental materials and lately, significant involvement of aesthetic filler materials as foreign bodies in the oral and perioral region have been reported. Foreign body granulomas (FBGs) may develop from this exogenous material, histopathologically characterized by the presence of chronic inflammation and a high amount of macrophages. This study presents nine FBG cases affecting the oral and perioral regions, and carries out a literature review on the main clinical, histopathological and material characteristics used in dental and dermatological procedures related to the appearance of this type of granuloma. Keywords.
    [Show full text]
  • Malignant Tenosynovial Giant Cell Tumor: the True €Œsynovial Sarcoma?€• a Clinicopathologic, Immunohistochemical
    Modern Pathology (2019) 32:242–251 https://doi.org/10.1038/s41379-018-0129-0 ARTICLE Malignant Tenosynovial Giant Cell Tumor: The True “Synovial Sarcoma?” A Clinicopathologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases, Supporting Origin from Synoviocytes 1 2 1 1 1 3 Alyaa Al-Ibraheemi ● William Albert Ahrens ● Karen Fritchie ● Jie Dong ● Andre M. Oliveira ● Bonnie Balzer ● Andrew L. Folpe1 Received: 5 July 2018 / Revised: 31 July 2018 / Accepted: 1 August 2018 / Published online: 11 September 2018 © United States & Canadian Academy of Pathology 2018 Abstract We present our experience with ten well-characterized malignant tenosynovial giant cell tumors, including detailed immunohistochemical analysis of all cases and molecular cytogenetic study for CSF1 rearrangement in a subset. Cases occurred in 7 M and 3 F (mean age: 52 years; range: 26–72 years), and involved the ankle/foot (n = 1), finger/toe (n = 3), wrist (n = 1), pelvic region (n = 3), leg (n = 1), and thigh (n = 1). There were eight primary and two secondary malignant 1234567890();,: 1234567890();,: tenosynovial giant cell tumors. Histologically, all cases showed definite areas of typical tenosynovial giant cell tumor. The malignant areas varied in appearance. In some cases, isolated malignant-appearing large mononuclear cells with high nuclear grade and mitotic activity were identified within otherwise-typical tenosynovial giant cell tumor, as well as forming larger masses of similar-appearing malignant cells. Occasionally, these nodules of malignant large mononuclear cells showed transition to pleomorphic spindle cell sarcoma, with varying degrees of collagenization and myxoid change. One malignant tenosynovial giant cell tumor was composed of sheets of monotonous large mononuclear cells with high nuclear grade, growing in a hyalinized, osteoid-like matrix, with areas of heterologous osteocartilaginous differentiation.
    [Show full text]
  • The Pathogenesis of Giant Cell Arteritis: Morphological Aspects
    The morphology of GCA / C. Nordborg et al. The pathogenesis of giant cell arteritis: Morphological aspects C. Nordborg1, E. Nordborg2, V. Petursdottir1 1Department of Pathology, 2Department of ABSTRACT in GCA. When studying V-beta families Rheumatology, Sahlgrenska University The light-microscopic, electron-micro- of the T-cell infiltrate with flow cyto- Hospital, Göteborg, Sweden. scopic and immunocytochemical charac- metry, Schaufelberger et al. found that These studies were supported by grants teristics of giant cell arteritis (GCA) the infiltrating lymphocytes are polyclo- from the Göteborg Medical Society, the have been investigated in a number of nal (3). On the other hand, Weyand et Swedish Heart-Lung Foundation, the studies on temporal arteries. Arterial al. (4) demonstrated the identical clonal Swedish Rheumatism Association, Rune atrophy and calcification of the internal expansion of a small proportion of the och Ulla Amlöfs Stiftelse and Syskonen elastic membrane appear to be prere- T-lymphocytes in separate segments of Holmströms Donationsfond. quisites for the evolution of the inflam- the same artery, which indicates antigen Please address correspondence and reprint matory process. Foreign body giant cells stimulation. A correlation between va- requests to: Claes Nordborg, Department form close to calcifications, apparently rious infections and the onset of GCA of Pathology, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden. without connection with other inflam- has been reported; it has been speculated E-mail: [email protected] matory cells and probably by the fusion that infectious disorders might trigger the of modified vascular smooth muscle inflammatory process (5). Zoster-vari- Clin Exp Rheumatol 2000: 18 (Suppl. 20): cells.
    [Show full text]
  • Double Layer Continuous Intradermal Sutures in Keloid Operation
    erimenta xp l D E e r & m l a a t c o i l n o i Journal of Clinical & Experimental Wang and Long, J Clin Exp Dermatol Res 2014, 5:1 l g y C f R DOI: 10.4172/2155-9554.1000205 o e l ISSN: 2155-9554 s a e n a r r u c o h J Dermatology Research Research Article Open Access Double Layer Continuous Intradermal Sutures in Keloid Operation Youbin Wang* and Xiao Long Plastic Surgery Department, Peking Union Medical College Hospital, Peking, China Abstract Objective: Keloid offten occurs on chest wall, shoulder and back. Surgical incision and postoperative radiation is an effective method in keloid treatment. Many of the wound in these places can be directly closed after keloids being removed. Recurrence prevention and cosmetic result should all be considered. Operation method especially suture method is one of the key issues which determine the treatment result. Many methods have been developed. However, many of them are designated to prevent recurrence. Cosmetic result is not fully considered. In this article, we reported a new suture method which is with good treatment and cosmetic results in our clinical study. Methods: One hundred and thirty-three patients with chest keloids were treated from 2006 to 2011. Double layer continuous intradermal suture was used in fifty four patients, interrupted epidermal suture was used in forty one patients, and one layer continuous intradermal suture was used in thirty eight patients. All operation sites were treated with radiotherapy on the first and seventh postoperative day. The follow-up time was from 9 to 26 months.
    [Show full text]
  • Foreign Body Granulomatous Reactions to Cosmetic Fillers
    J Clin Exp Dent. 2012;4(4):e244-7. Foreign body granulomatous reactions. Journal section: Oral Medicine and Pathology doi:10.4317/jced.50868 Publication Types: Review http://dx.doi.org/10.4317/jced.50868 Foreign body granulomatous reactions to cosmetic fillers Laura Carlos-Fabuel, Cristina Marzal-Gamarra, Silvia Martí-Álamo, Aisha Mancheño-Franch DDS. Master in Oral Medicine and Surgery. University of Valencia. Valencia (Spain). Correspondence: Clínica Odontológica Gascó Oliag 1 46021 – Valencia (Spain) E-mail: [email protected] Carlos-Fabuel L, Marzal-Gamarra C, Martí-Álamo S, Mancheño-Franch A. Foreign body granulomatous reactions to cosmetic fillers. J Clin Exp Received: 02/05/2012 Dent. 2012;4(4):e244-7. Accepted: 04/05/2012 http://www.medicinaoral.com/odo/volumenes/v4i4/jcedv4i4p244.pdf Article Number: 50868 http://www.medicinaoral.com/odo/indice.htm © Medicina Oral S. L. C.I.F. B 96689336 - eISSN: 1989-5488 eMail: [email protected] Indexed in: Scopus DOI® System Abstract Introduction: The use of different facial cosmetic fillers has increased in recent years. The introduction of appa- rently inert substances in the epidermis can give rise to foreign body granulomatous reactions. Objetives: A literature review is made of the foreign body granulomatous reactions to cosmetic fillers. Material and methods: A PubMed-Medline search was made using the following keywords: “granulomatous reac- tions”, “foreign body reactions”, “esthetic fillers”, “cosmetic fillers”. The search was limited to articles published in English and Spanish during the last 10 years. A total of 22 articles were reviewed. Results: A great variety of substances have been found to give rise to foreign body granulomatous reactions.
    [Show full text]
  • An Unusual Cause of Hyperkeratosis
    An Unusual Cause of Hyperkeratosis Dr. J. White, ST5 Histopathology, Dr. A. Bakshi, Consultant Dematopathologist Clinical Presentation • 43-year-old • Two and a half year history • Pink/light brown papules, some of which appeared scaly and keratotic • Started on her ankle and lower legs and spread to her thighs, arms and neck Clinical Presentation Histology Differential Diagnosis • 1) Keratosis pilaris • 2) Lichen planus • 3) Hyperkeratosis follicularis et parafollicularis in cutem pentetrans (Kyrle’s disease) • 4) Hyperkeratosis lenticularis perstans (Flegel’s disease) • 5) Lichenoid drug reaction Keratosis Pilaris 1 • Peak in adolescence 2 • Association with ichthyosis vulgaris • Pruritic, follicular papules & pustules • Lateral aspect arms & thighs • Histology – follicular dilatation & keratin plugs • May contain distorted hair shafts Lichen Planus 3 • Violaceous papules 4 • Intensely pruritic • Flexor aspects wrists & forearms, extensor aspects hand & ankles • Histology - Interface dermatitis • Irregular acanthosis • (Wedge-shaped) Hypergranulosis Kyrle’s Disease 5 • Similar clinical presentation 6 to our patient (age, gender, distribution), palms & soles classically spared • Histology- epidermal invagination containing keratotic plug & basophilic debris • Eventual perforation into dermis with associated foreign-body reaction & subsequent transepidermal elimination Lichenoid Drug Reaction 7 • Clinically similar presentation to lichen 8 planus • Gold, anti-malarials, penicillamine, captopril, β-blockers, TNF-α inhibitors • May be a
    [Show full text]